Perineural Invasion in Adenoid Cystic Carcinoma of the Salivary Glands: Where We Are and Where We Need to Go

被引:37
|
作者
Liu, Xiaohao [1 ]
Yang, Xiaojun [1 ]
Zhan, Chaoning [1 ]
Zhang, Yan [1 ]
Hou, Jin [1 ]
Yin, Xuemin [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Oral & Maxillofacial Surg, Guangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
adenoid cystic carcinoma; salivary glands; perineural invasion; tumor microenvironment; perineurium barrier; TIGHT JUNCTION PROTEINS; NERVE GROWTH-FACTOR; PANCREATIC-CANCER; EXTRACELLULAR VESICLES; NECK-CANCER; NEUROTROPHIC FACTOR; PROGNOSTIC-FACTORS; SURGICAL MARGINS; POOR-PROGNOSIS; STELLATE CELLS;
D O I
10.3389/fonc.2020.01493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adenoid cystic carcinoma of the salivary gland (SACC) is a rare malignant tumors of the head and neck region, but it is one of the most common malignant tumors that are prone to perineural invasion (PNI) of the head and neck. The prognosis of patients with SACC is strongly associated with the presence of perineural spread (PNS). Although many contributing factors have been reported, the mechanisms underlying the preferential destruction of the blood-nerve barrier (BNB) by tumors and the infiltration of the tumor microenvironment by nerve fibers in SACC, have received little research attention. This review summarizes the current knowledge concerning the characteristics of SACC in relation to the PNI, and then highlights the interplay between components of the tumor microenvironment and perineural niche, as well as their contributions to the PNI. Finally, we provide new insights into the possible mechanisms underlying the pathogenesis of PNI, with particular emphasis on the role of extracellular vesicles that may serve as an attractive entry point in future studies.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The Holocaust -: Where we are, where we need to go
    Jäckel, E
    HOLOCAUST AND HISTORY: THE KNOWN, THE UNKNOWN, THE DISPUTED, AND THE REEXAMINED, 1998, : 23 - 29
  • [2] Anticoagulation: where we are and where we need to go
    Barnes, Geoffrey D.
    Froehlich, James B.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (02) : 220 - 223
  • [3] Synucleinopathies: Where we are and where we need to go
    Bras, Ines Caldeira
    Dominguez-Meijide, Antonio
    Gerhardt, Ellen
    Koss, David
    Lazaro, Diana F.
    Santos, Patricia, I
    Vasili, Eftychia
    Xylaki, Mary
    Outeiro, Tiago Fleming
    JOURNAL OF NEUROCHEMISTRY, 2020, 153 (04) : 433 - 454
  • [4] Anticoagulation: where we are and where we need to go
    Geoffrey D. Barnes
    James B. Froehlich
    Journal of Thrombosis and Thrombolysis, 2009, 28
  • [5] Perineural invasion in adenoid cystic carcinoma of the salivary glands: A valid prognostic indicator?
    Barrett, A. William
    Speight, Paul M.
    ORAL ONCOLOGY, 2009, 45 (11) : 936 - 940
  • [6] Diversity in Neuromodulators: Where We Are and Where We Need to Go
    Sabourin, Shelby
    Omoruan, Moje
    Khazen, Olga
    DiMarzio, Marisa
    Sofatzis, Tia
    Staples, Sarah
    Feustel, Paul J.
    Petersen, Erika
    Casini, Gianna
    Spinoza, Zulma T.
    Pilitsis, Julie G.
    NEUROMODULATION, 2020, 23 (02): : 145 - 149
  • [7] Pharmacoeconomics in 2000: Where we are, where we need to go
    Lyles, A
    FORMULARY, 2000, 35 (05) : 422 - +
  • [8] Measuring acculturation: Where we are and where we need to go
    Cabassa, LJ
    HISPANIC JOURNAL OF BEHAVIORAL SCIENCES, 2003, 25 (02) : 127 - 146
  • [9] The Holocaust - Where we are, where we need to go - A comment
    Marrus, MR
    HOLOCAUST AND HISTORY: THE KNOWN, THE UNKNOWN, THE DISPUTED, AND THE REEXAMINED, 1998, : 30 - 34
  • [10] Molecular oncodiagnostics: Where we are and where we need to go
    Liu, ET
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) : 2052 - 2055